Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Glob Health ; 13: 04083, 2023 Aug 11.
Article in English | MEDLINE | ID: mdl-37566690

ABSTRACT

Background: High prices of targeted anticancer medicines (TAMs) result in financial toxicity for patients and the health insurance system. How national price negotiation and reimbursement policy affect the accessibility of TAMs for cancer patients remains unknown. Methods: In this population-based cohort study, we used national health insurance claims data in 2017 and identified adult patients with cancer diagnoses for which price-negotiated TAMs were indicated. We estimated the half-month prevalence of price-negotiated TAMs use before and after the policy implementation in September 2017. We calculated direct medical costs, out-of-pocket (OOP) costs, and the proportion of OOP cost for each cancer patient to measure their financial burden attributable to TAMs use. We performed segmented linear and multivariable logistic regression to analyse the policy impact. Results: We included 39 391 of a total 118 655 cancer beneficiaries. After September 2017, the prevalence of price-negotiated TAMs use increased from 1.4%-2.1% to 2.9%-3.1% (P = 0.005); TAMs users' daily medical costs increased from US$261.3 to US$292.5 (P < 0.001), while median daily OOP costs (US$68.2 vs US$65.7; P = 0.134) and OOP costs as a proportion of daily medical costs persisted (28.5% vs 28.5%; P = 0.995). Compared with resident beneficiaries, the relative probability of urban employee beneficiaries on TAMs uses decreased after the policy (adjusted odds ratio (aOR) = 2.4 vs aOR = 2.2). Conclusions: The government price negotiation and reimbursement policy improved patient access to TAMs and narrowed disparities among insurance schemes. China's approach to promoting the affordability of expensive medicines provides valuable experience for health policy decision-makers.


Subject(s)
Antineoplastic Agents , Neoplasms , Adult , Humans , Cohort Studies , Negotiating , Antineoplastic Agents/therapeutic use , Insurance, Health , Neoplasms/drug therapy , Health Expenditures , National Health Programs , Government , China/epidemiology
2.
J Speech Lang Hear Res ; 63(1): 286-304, 2020 01 22.
Article in English | MEDLINE | ID: mdl-31855606

ABSTRACT

Purpose The current study investigates how individual differences in cochlear implant (CI) users' sensitivity to word-nonword differences, reflecting lexical uncertainty, relate to their reliance on sentential context for lexical access in processing continuous speech. Method Fifteen CI users and 14 normal-hearing (NH) controls participated in an auditory lexical decision task (Experiment 1) and a visual-world paradigm task (Experiment 2). Experiment 1 tested participants' reliance on lexical statistics, and Experiment 2 studied how sentential context affects the time course and patterns of lexical competition leading to lexical access. Results In Experiment 1, CI users had lower accuracy scores and longer reaction times than NH listeners, particularly for nonwords. In Experiment 2, CI users' lexical competition patterns were, on average, similar to those of NH listeners, but the patterns of individual CI users varied greatly. Individual CI users' word-nonword sensitivity (Experiment 1) explained differences in the reliance on sentential context to resolve lexical competition, whereas clinical speech perception scores explained competition with phonologically related words. Conclusions The general analysis of CI users' lexical competition patterns showed merely quantitative differences with NH listeners in the time course of lexical competition, but our additional analysis revealed more qualitative differences in CI users' strategies to process speech. Individuals' word-nonword sensitivity explained different parts of individual variability than clinical speech perception scores. These results stress, particularly for heterogeneous clinical populations such as CI users, the importance of investigating individual differences in addition to group averages, as they can be informative for clinical rehabilitation. Supplemental Material https://doi.org/10.23641/asha.11368106.


Subject(s)
Cochlear Implants/psychology , Deafness/psychology , Individuality , Phonetics , Speech Perception , Acoustic Stimulation/methods , Adult , Aged , Cochlear Implantation , Deafness/surgery , Female , Humans , Male , Middle Aged , Task Performance and Analysis
3.
J Pharm Policy Pract ; 11: 23, 2018.
Article in English | MEDLINE | ID: mdl-30356941

ABSTRACT

A strong pharmaceutical sector is a precondition for effective and efficient health care and financing systems, and thus for achieving the best possible health of a population. Supported by visionary, long-term donor funds, in conjunction with mutual trust, the USAID-funded Securing Ugandans Rights to Essential Medicines (SURE) and Uganda Health Supply Chain (UHSC) program engaged in a close, more than 10 year-long (in 2018) collaboration with the Ministry of Health of Uganda. Over time, the partnership implemented numerous multi-pronged comprehensive changes in the pharmaceutical sector and conducted research to document successes and failures. We describe the evolution and key characteristics of the SURE/UHSC interventions.

4.
IEEE Trans Neural Syst Rehabil Eng ; 26(2): 392-399, 2018 02.
Article in English | MEDLINE | ID: mdl-29432110

ABSTRACT

Electroencephalographic (EEG) recordings provide objective estimates of listeners' cortical processing of sounds and of the status of their speech perception system. For profoundly deaf listeners with cochlear implants (CIs), the applications of EEG are limited because the device adds electric artifacts to the recordings. This restricts the possibilities for the neural-based metrics of speech processing by CI users, for instance to gauge cortical reorganization due to individual's hearing loss history. This paper describes the characteristics of the CI artifact as recorded with an artificial head substitute, and reports how the artifact is affected by the properties of the acoustical input signal versus the settings of the device. METHODS: We created a brain substitute using agar that simulates the brain's conductivity, placed it in a human skull, and performed EEG recordings with CIs from three different manufacturers. As stimuli, we used simple and complex non-speech stimuli, as well as naturally produced continuous speech. We examined the effect of manipulating device settings in both controlled experimental CI configurations and real clinical maps. RESULTS: An increase in the magnitude of the stimulation current through the device settings increases also the magnitude of the artifact. The artifact recorded to speech is smaller in magnitude than for non-speech stimuli due to signal-inherent amplitude modulations. CONCLUSION: The CI EEG artifact for speech appears more difficult to detect than for simple stimuli. Since the artifact differs across CI users, due to their individual clinical maps, the method presented enables insight into the individual manifestations of the artifact.


Subject(s)
Acoustic Stimulation , Artifacts , Brain/physiology , Cochlear Implants , Electroencephalography/methods , Models, Neurological , Agar , Brain Mapping , Electric Conductivity , Evoked Potentials, Auditory , Humans , Models, Anatomic , Skull
5.
J Pharm Policy Pract ; 9: 19, 2016.
Article in English | MEDLINE | ID: mdl-27158514

ABSTRACT

This editorial introduces a series of case studies that together highlight the use of health market interventions to improve access to medicines in low-and-middle income countries (LMICs). It underscores the added value of using a systems approach for a holistic understanding of how these interventions interact with the rest of the health system and the intended and unintended consequences that result. It goes on to summarize key findings from each of the studies and concludes with lessons for decision-makers on the design and implementation of market based interventions in LMIC health systems.

6.
J Acoust Soc Am ; 139(4): 1799, 2016 04.
Article in English | MEDLINE | ID: mdl-27106328

ABSTRACT

Cross-language differences in speech perception have traditionally been linked to phonological categories, but it has become increasingly clear that language experience has effects beginning at early stages of perception, which blurs the accepted distinctions between general and speech-specific processing. The present experiments explored this distinction by playing stimuli to English and Japanese speakers that manipulated the acoustic form of English /r/ and /l/, in order to determine how acoustically natural and phonologically identifiable a stimulus must be for cross-language discrimination differences to emerge. Discrimination differences were found for stimuli that did not sound subjectively like speech or /r/ and /l/, but overall they were strongly linked to phonological categorization. The results thus support the view that phonological categories are an important source of cross-language differences, but also show that these differences can extend to stimuli that do not clearly sound like speech.


Subject(s)
Discrimination, Psychological , Phonetics , Speech Acoustics , Speech Perception , Acoustic Stimulation , Acoustics , Adolescent , Adult , Audiometry, Speech , Humans , Middle Aged , Sound Spectrography , Young Adult
7.
Health Policy ; 116(2-3): 196-205, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24314624

ABSTRACT

OBJECTIVES: To control increasing pharmaceutical expenditures, Taiwan's National Health Insurance has implemented a series of drug reimbursement price reductions since 2000. This study examined changes in use and expenditures of oral antidiabetic medications following the price regulation in November 2006. METHODS: We obtained claims data between January 2006 and August 2007 from Taiwan's National Health Insurance Research Database. We categorized oral antidiabetic products as affected by the reimbursement reduction ("targeted") or not ("non-targeted"), by level of relative price reduction, and by manufacturer type (international vs. local manufacturers). We used an interrupted time series design and segmented regression models to estimate changes in monthly per capita prescribing rate, volume, and insurance reimbursement expenditures following the policy. RESULTS: The majority (129/178; 72.5%) of oral antidiabetic products were targeted by this round of price reductions. There was a relative reduction of 9.5% [95%CI: -12.68, -6.32] in total expenditures at ten months post-policy compared to expected rates. For targeted products, there were 2.04% [95%CI: -4.15, 0.07] and 13.26% [95%CI: -16.64, -9.87] relative reductions in prescribing rate and expenditures, respectively, at ten months post-policy. Non-targeted products increased significantly (22% [95%CI: 10.49, 33.51] and 22.85% [95%CI: 11.69, 34.01] relative increases in prescribing rate and expenditures respectively). Larger reimbursement cuts led to greater reductions in prescribing rate, volume, and insurance reimbursement expenditures of targeted products. Prescribing rates of both targeted and non-targeted products by international manufacturers declined after the policy while rates of prescribing non-targeted products by local manufacturers increased. CONCLUSIONS: While total government expenditures for oral antidiabetic medications were contained by the policy, our results indicate that prescribing shifted at the margin from targeted to non-targeted products and from international to local products. Further research is warranted to understand how changes in medication use due to price regulation policies affect medication adherence and patient health outcomes.


Subject(s)
Drug Costs/statistics & numerical data , Hypoglycemic Agents/therapeutic use , Humans , Hypoglycemic Agents/economics , Interrupted Time Series Analysis , National Health Programs/organization & administration , National Health Programs/statistics & numerical data , Reimbursement Mechanisms/economics , Reimbursement Mechanisms/organization & administration , Reimbursement Mechanisms/statistics & numerical data , Taiwan/epidemiology
8.
J Acoust Soc Am ; 130(5): EL297-303, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22088031

ABSTRACT

This study examined the perceptual specialization for native-language speech sounds, by comparing native Hindi and English speakers in their perception of a graded set of English /w/-/v/ stimuli that varied in similarity to natural speech. The results demonstrated that language experience does not affect general auditory processes for these types of sounds; there were strong cross-language differences for speech stimuli, and none for stimuli that were nonspeech. However, the cross-language differences extended into a gray area of speech-like stimuli that were difficult to classify, suggesting that the specialization occurred in phonetic processing prior to categorization.


Subject(s)
Multilingualism , Phonetics , Speech Acoustics , Speech Intelligibility , Speech Perception , Acoustic Stimulation , Adolescent , Adult , Audiometry, Speech , Cues , Humans , Young Adult
9.
BMC Health Serv Res ; 10: 211, 2010 Jul 17.
Article in English | MEDLINE | ID: mdl-20637116

ABSTRACT

BACKGROUND: The current health care reform in China launched in 2009 tackles the problem of access to appropriate medicines for its 1.3 billion people by focusing on providing essential medicines to all. To provide evidence for the reform process, we investigated the manufacturing, purchasing, and prescribing of essential medicines in two provinces. METHODS: We conducted surveys in 2007 of all manufacturers (n = 253) and of 59 purposively selected retail and 63 hospital pharmacies in Shandong and Gansu provinces to assess production and supply of products on the 2004 National Essential Medicines List (NEML), as well as factors underlying decision making about production and supply. We also reviewed prescriptions (n = 5456) in health facilities to calculate standard indicators of appropriate medicines use. RESULTS: Overall, manufacturers in Shandong and Gansu produced only 62% and 50%, respectively, of the essential medicines they were licensed to produce. Of a randomly selected 10% of NEML products, retail pharmacies stocked up to 60% of Western products. Median availability in hospital pharmacies ranged from 19% to 69%. Manufacturer and retail pharmacy managers based decisions on medicines production and stocking on economic considerations, while hospital pharmacy managers cited clinical need. Between 64% and 86% of prescriptions contained an essential medicine. However, overprescribing of antibiotics (34%-77% of prescriptions) and injectables (22%-61%) for adult non-infectious outpatient consultations was common. CONCLUSIONS: We found that manufacturers, retail pharmacies, and hospital pharmacies paid limited attention to China's 2004 NEML in their decisions to manufacture, purchase, and stock essential medicines. We also found that prescribing of essential medicines was frequently inappropriate. These results should inform strategies to improve affordable access to essential medicines under the current health care reform.


Subject(s)
Drug Prescriptions/statistics & numerical data , Drug Utilization Review , Drugs, Essential/supply & distribution , Administrative Personnel , Adult , China , Commerce/statistics & numerical data , Data Collection , Drug Industry/statistics & numerical data , Drugs, Chinese Herbal/supply & distribution , Drugs, Essential/economics , Health Services Accessibility , Health Services Misuse/statistics & numerical data , Humans , Interviews as Topic , Pharmacies/statistics & numerical data , Pharmacists , Pharmacopoeias as Topic , Pharmacy Service, Hospital/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL